Aurora Cannabis Inc. (ACB) is making waves in the cannabis industry with its innovative research into auto-flowering technology. This groundbreaking technology allows cannabis plants to automatically transition from the vegetative stage to the flowering stage, eliminating the need to rely on changes in light cycles. This is particularly significant for high-latitude regions, such as Canada, where traditional cannabis cultivation can be challenging due to shorter days and limited sunlight.
Aurora’s research, which has resulted in a US Patent 12,002,546 titled “Methods of Determining Sensitivity to Photoperiod in Cannabis,” provides valuable insights into the flowering mechanism in cannabis. This knowledge will be instrumental in developing future breeding strategies and enhancing outdoor cultivation practices.
“As a company backed by science, we have long invested in research both independently and with leading academic institutions, and have achieved significant learning from our work,” said Jose Celedon, PhD, director of breeding and genetics at Aurora. “Our recent work on auto-flowering will be a game-changer for cannabis and hemp production.”
This innovative approach to cannabis cultivation is expected to revolutionize the industry. Aurora’s research and development efforts have yielded significant improvements in potency, yield, and overall efficiency, leading to lower production costs and higher returns.
In addition to its research endeavors, Aurora recently collaborated with Vectura Fertin Pharma, Inc. to introduce the Luo CBD lozenge, its first medical cannabis CBD lozenge to be launched in Canada. This product, developed by Vectura Fertin Pharma, signifies Aurora’s commitment to providing innovative and effective healthcare solutions.
Aurora’s dedication to scientific innovation and its groundbreaking research on auto-flowering technology are poised to transform the cannabis industry. The company’s commitment to improving production efficiency, enhancing potency, and developing new healthcare products is a testament to its leadership in the evolving cannabis market.
